The Benefits of AI for Earlier Autosomal Dominant Polycystic Kidney Disease (ADPKD) Risk Identification
|Dr. Andrew Steele, Medical Director and Section Chief of Nephrology and Diabetes at Lakeridge Health.|
|Dr. Nadia Alam, Primary Care Physician in Halton, U of T Faculty and Past President of the OMA.|
After participating in the online live event, physicians should be able to:
This live stream has been supported by an educational grant from Khure Health.
Views and opinions in this program are of the faculty and not necessarily endorsed by, or reflective of, those of the publisher of www.healthplexus.net and Journal of Current Clinical Care.